Drug Shortage Report for PMS-ZOLPIDEM ODT
Report ID | 235748 |
Drug Identification Number | 02436183 |
Brand name | PMS-ZOLPIDEM ODT |
Common or Proper name | ZOLPIDEM ODT |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ZOLPIDEM TARTRATE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | SUBLINGUAL SUBLINGUAL |
Packaging size | 30 |
ATC code | N05CF |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-08-22 |
Estimated end date | 2024-09-29 |
Actual end date | 2024-09-29 |
Shortage status | Resolved |
Updated date | 2024-09-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-09-30 | French | Compare |
v4 | 2024-09-30 | English | Compare |
v3 | 2024-09-30 | English | Compare |
v2 | 2024-08-23 | French | Compare |
v1 | 2024-08-23 | English | Compare |
Showing 1 to 5 of 5